Speaker(s):
Jessica Coombs, MHA, RRT, RRT-ACCS, Staff Member, Geisinger - has nothing to disclose.
Learning Objectives:
At the conclusion of this session, the participant should be able to:
- Define Primary Ciliary Dyskinesia (PCD)
- Discuss possible treatments for PCD
- Define new accepted definition of exacerbation of PCD
- Discuss difference in Cystic Fibrosis, non-CF bronchiectasis, and primary ciliary dyskinesia.
Disclosure of Relevant Financial Relationships with/without Commercial Interests:
The Planning Committee consisting of Katie Ritz RRT-NPS, Katelyn Green, Mark Williams, RN, BSN, and Dr Ronald Wong, DO have no identified disclosures.
CE Committee Member/Content Reviewers have nothing to disclose.
Any/All relevant financial relationships have been mitigated.
Content Disclosure:
This presentation/content is HIPAA compliant.
Commercial Support for this Session
None
Session date:
02/12/2025 - 7:30am to 8:30am EST
Location:
Virtual via Microsoft Teams
Danville, PA
17822
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
- 1.00 Participation Credit